EMV has continued to impress with a tight capital structure and overwhelming demand. Capital Raise loose stock has been mostly absorbed in its pull back from $0.99 back down to $0.66. Once supply dwindled it was quite clear the bulls are fully in charge of the EMV trend.
A C&H formation with a cup spread of 33.5c and what appears to be handle forming the last weekly session, although proper confirmation is still required this could indicated a continuation pattern with a target of $1.27.
With material news nearing as EMVision continues pushing forward through its Pilot Clinical trial, the price action could coincide well with the expected news flow. Additionally the potential for a Research Grant through EMV's partner 'Australian Stroke Alliance' in the event it was successful could see a significant rerate and possibly fiscally pave the way for all future trial expenses. (I stress that this is not a certainty, but I am optimistic of EMV's chances.)
EMV is an easy hold for me, with a 2-3 year vision in my trading plan.
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.